Logo

Boehringer-Ingelheim

Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug

The companies will develop the FoundationOne CDx test as a companion diagnostic for Boehringer Ingelheim's BI 907828 in the US, Japan, and EU.

Boehringer Ingelheim, BiomX Embark on New Inflammatory Bowel Disease Biomarker Discovery Project

The deal is the second of its kind for the two companies following a 2020 partnership to investigate metagenomic markers of different IBD patient phenotypes.

Lifebit, Boehringer Ingelheim Collaborate on Data, Analytics for Drug Discovery

Lifebit Biotech will help Boehringer Ingelheim build a scaleable clinicogenomics data platform in the cloud.

Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference

The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent.

Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC

Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients.

Sep 2, 2020

BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery

Jun 6, 2019

TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts
Premium

Feb 27, 2019

Boehringer Ingelheim, GNA Biosolutions Partner on African Swine Fever Dx

Jan 18, 2018

Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug

Oct 12, 2017

NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative

Jun 6, 2017

New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer
Premium

Feb 8, 2017

Penn Medicine Gets $3M From Pharma Consortium for Diabetic Kidney Disease Study

Oct 24, 2016

Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients
Premium

Apr 27, 2015

Survey Shows More NSCLC Patients Getting EGFR Testing, but Results Often Don't Inform Care
Premium

Nov 13, 2014

Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research
Premium

Oct 31, 2014

Boehringer Ingelheim Taps IDBS’ E-WorkBook Suite to Support R&D
Premium

Sep 24, 2014

With Boehringer Support, NCCN Awards Grants to Advance Evidence-based Development of Nintedanib
Premium

Nov 6, 2013

Drugmakers in Third Quarter Focus on Uptake of Newer Personalized Rx to Replace Older Versions
Premium

Sep 25, 2013

Boehringer Enlists Roche Subsidiary Ventana for Companion Dx Help
Premium

Sep 19, 2013

Ventana, Boehringer Ingelheim to Collaborate on CDx for Cancer Drugs

Sep 4, 2013

After FDA Approval, Boehringer Ingelheim Launching PGx NSCLC Drug Gilotrif in US
Premium

Sep 3, 2013

Diaxonhit, Boehringer Ingelheim Collaborate on Cancer Therapeutic Targets

Aug 14, 2013

Roche's HER2 Breast Cancer Segment Tops List of PGx Drug Sales in Q2
Premium

Jul 18, 2013

Dx Focus: FDA Approves Qiagen Therascreen EGFR RGQ; Luminex xTAG CYP2D6 Kits
Premium

Jul 17, 2013

FDA Okays Boehringer's Gilotrif, Qiagen EGFR Test, Providing New PGx Options for Advanced NSCLC
Premium

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.